VIVEVE MEDICAL, INC. 4
4 · VIVEVE MEDICAL, INC. · Filed Mar 7, 2017
Insider Transaction Report
Form 4
Durbin Scott
Chief Financial Officer
Transactions
- Award
Incentive Stock Option (Right to Purchase)
2017-03-03+132,860→ 132,860 totalExercise: $4.46Exp: 2027-03-02→ Common Stock (132,860 underlying)
Footnotes (1)
- [F1]The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 132,860 incentive stock options on March 3, 2017 (the "Grant Date"). The incentive stock options will vest in equal monthly increments over 48 months following the Grant Date.